Personalized anti-cancer vaccine combining mRNA and immunotherapy tested in melanoma trial von Carvalho, Thiago

Volltext

mRNA vaccine effective against RSV respiratory disease von Carvalho, Thiago

Volltext

Stem cell–derived heart cells injected into first patient von Carvalho, Thiago

Volltext

Intranasal COVID-19 vaccine fails to induce mucosal immunity von Carvalho, Thiago

Volltext

Anti-CD40L antibody frexalimab slows new brain lesions in multiple sclerosis von Carvalho, Thiago

Volltext

New depression drug zuranolone one step closer to FDA ruling von Carvalho, Thiago

Volltext

FDA approves first drug to delay type 1 diabetes von Carvalho, Thiago

Volltext

Discontinued CRISPR gene therapy for sickle-cell disease improves symptoms von Carvalho, Thiago

Volltext

Two US surgical teams transplant functional pig kidneys into humans in xenotransplantation success von Carvalho, Thiago

Volltext

The unknown efficacy of tecovirimat against monkeypox von Carvalho, Thiago

Volltext

RNA interference treatment targeting angiotensinogen lowers blood pressure von Carvalho, Thiago

Volltext

CRISPR–Cas9 hits its target in amyloidosis von Carvalho, Thiago

Volltext

FDA approves Genentech’s bispecific antibody for lymphoma von Carvalho, Thiago

Volltext

The first 12 months of COVID-19: a timeline of immunological insights von Carvalho, Thiago, Krammer, Florian, Iwasaki, Akiko

Volltext

mRNA vaccines boost BioNTech’s CAR T cell therapy von Carvalho, Thiago

Volltext

Biomarker data prove critical for ALS drug evaluation at FDA von Carvalho, Thiago

Volltext

COVID-19-induced Kawasaki disease von Carvalho, Thiago

Volltext

Interferon linked to COVID-19 severity von Carvalho, Thiago

Volltext

Cross-reactive T cells von Carvalho, Thiago

Volltext

Silent spread von Carvalho, Thiago

Volltext